Skip to main content
Download PDF

Venous thromboembolism after arthroscopic shoulder surgery: a systematic review

Journal of Orthopaedic Surgery and Research volume 18, Article number: 103 (2023) Cite this article

Abstract

Purpose

To summarize the incidence, risk factors, diagnosis methods, prophylaxis methods, and treatment of venous thromboembolism (VTE) following arthroscopic shoulder surgery.

Methods

Literature on VTE after arthroscopic shoulder surgeries was summarized, and all primary full-text articles reporting at least 1 case of deep vein thrombosis (DVT) or pulmonary embolism (PE) after arthroscopic shoulder surgeries were included. Articles were critically appraised and systematically analyzed to determine the incidence, risk factors, diagnosis, prophylaxis, and management of VTE following arthroscopic shoulder surgeries.

Results

This study included 42 articles in which the incidence of VTE ranges from 0 to 5.71% and the overall incidence was 0.26%. Most VTE events took place between the operation day and the 14th day after the operation (35/51). Possible risk factors included advanced age (> 70 years), obesity (BMI ≥ 30 kg/m2), diabetes mellitus, thrombophilia, history of VTE, prolonged operation time, hormone use, and immobilization after surgery. The most common prophylaxis method was mechanical prophylaxis (13/15). No statistical difference was detected when chemoprophylaxis was applied. The management included heparinization followed by oral warfarin, warfarin alone and rivaroxaban, a direct oral anticoagulant.

Conclusion

Based on the included studies, the incidence rate of VTE after arthroscopic shoulder surgeries is relatively low. The risk factors for VTE are still unclear. CT/CTA and ultrasound were the mainstream diagnosis methods for PE and DVT, respectively. Current evidence shows that chemical prophylaxis did not deliver significant benefits, since none of the existing studies reported statistically different results. High-quality studies focusing on the prophylaxis and management of VTE population undergoing arthroscopic shoulder surgeries should be done in the future.

Introduction

Frequent shoulder dysfunction is the third cause of musculoskeletal consultations in primary health care [1]. The majority of shoulder dysfunction is caused by trauma and degenerative diseases such as arthritis, rotator cuff (RC) injuries and shoulder instabilities [2,3,4,5]. For most of those who need surgical therapy, arthroscopic surgery can be a good option since it allows for less trauma to the deltoid, less risk of axillary nerve palsy, less immediate postoperative pain, decreased operation time and better cosmetic results [6, 7]. Besides, recent studies of multi-institutional outcome databases reported low overall rates of complications (1.0–1.6%) and low infection rates after arthroscopic shoulder surgery [8, 9].

With these advantages, the use of the arthroscopic shoulder surgery has expanded greatly [10, 11]. However, despite the application of arthroscopy, venous thromboembolism (VTE), including deep vein thrombosis (DVT) and pulmonary embolism (PE), is still known to be a serious, sometimes even life-threatening, complications following elective upper extremity surgeries [12]. Approximately 20–50% of VTE patients suffered post-thrombotic syndrome, which is detrimental to their quality of life due to chronic hyperpigmentation, edema, pruritus, pain, and ulceration [13].

To reduce and even eliminate the occurrence of VTE, identifying the risk factors is very crucial [14]. Some studies pointed out that comorbidities associated with greater VTE risk include advanced age (≥ 70 years), VTE history, BMI > 40, diabetes mellitus (insulin-dependent and non-insulin-dependent), chronic lung disease and Charlson Comorbidity Index (CCI) ≥ 1 [15,16,17,18,19,20,21,22]. However, little information regarding the risk factors and implementation of preventive measures for VTE after arthroscopic shoulder surgeries have been reported. Therefore, the decision to provide prophylaxis to this population of patients remains subject to the surgeons’ discretion and personal experience. Following an extensive literature search, this systematic review aims to summarize the incidence, risk factors, diagnosis methods, preventive measures and management of VTE after arthroscopic shoulder surgeries and detect the efficacy of chemoprophylaxis in these cases. The hypothesis was that the risk factors for VTE after arthroscopic shoulder surgeries were similar to those mentioned above and the chemoprophylaxis was unnecessary in these cases.

Methods

Search strategy

This systematic review was performed following the Preferred Reporting Items for Systematic Reviews and Meta-Analyses (PRISMA) guidelines. The PubMed, Embase, Cochrane Library and Web of Science databases were queried using the following strategy: (“Arthroscopy”[MeSH] OR “shoulder arthroscopy” OR “shoulder”[MeSH]) AND (“Venous Thromboembolism” OR “VTE” OR “deep vein thrombosis” OR “DVT” OR “Upper Extremity Deep Vein Thrombosis” OR “Pulmonary Embolism” OR “vein embolism” OR “pulmonary thromboembolisms” OR “PE” OR “Venous Thromboembolism”[MeSH] OR “Venous Thrombosis”[MeSH] OR “Upper Extremity Deep Vein Thrombosis”[MeSH] OR “Pulmonary Embolism”[MeSH]). The keywords were restricted to the title or abstract. The search was conducted on September 5, 2021.

Study selection and quality assessment

Two reviewers screened and assessed the studies independently. Two senior authors (one shoulder surgeon and one pulmonary disease expert) reviewed discrepancies and made the final decision. The inclusion criteria for the studies were as follows: (1) with postoperative complications after arthroscopic shoulder surgeries reported; (2) published in a peer-reviewed journal; (3) published in English and (4) full text available. The exclusion criteria for the studies were as follows: (1) basic science studies; (2) only abstracts, review articles or editorial comments; (3) animal or cadaveric studies; and (4) incomplete data. Based on these inclusion and exclusion criteria, the title and abstract of each of the papers were screened first, and the full texts of potentially relevant studies were subsequently reviewed. For those studies with data from the same public databases, the reviewers reached a consensus that only the more recent studies would be included lest some patients be counted repeatedly.

Based on the results of previous literature search, no randomized study on this topic was retrieved. The quality of case series, case control studies and cohort studies was evaluated using the methodological index for non-randomized studies (MINORS), which was designed to assess the quality of both comparative and non-comparative studies. MINORS contains 8 items for non-comparative studies and 12 for comparative studies. Each item is scored 0 (not reported), 1 (reported but inadequate) or 2 (reported and adequate) [23]. As for case reports, Joanna Briggs Institute (JBI) Critical Appraisal checklist was adopted. JBI Critical Appraisal checklist for case reports contains 8 items. Each item has 4 grades, which are yes, no, unclear and not applicable. If more than one of the items was rated as no, then the study would be excluded. The two independent reviewers appraised the quality of included studies, and any disagreements were resolved by the senior researchers.

Data extraction

Data from included studies were extracted into the excel sheets by two reviewers. VTE events included DVT (total, proximal, and distal), PE or both, up to 6 weeks post-discharge. The proximal DVT included thrombus in popliteal or common femoral vein and the distal ones included those in the distal part of the popliteal vein (tibial and peroneal veins). PE was defined as having thrombus in the segmental or larger arteries of lungs. The extracted data included blind methods, surgical procedures, number of patients, number of VTE complications, diagnostic methods of VTE, prophylaxis methods of VTE, VTE management and efficacy, mortality, follow-up time and other VTE-related information.

Results

Study selection and quality assessment

The results of our literature search are shown in Fig. 1. The search resulted in 2524 potentially relevant titles, including 627 duplicate articles. After the screening of the abstracts for relevance, we analyzed the remaining 97 full-text articles based on the predetermined inclusion criteria. A total of 42 articles met the inclusion criteria and were included in this systematic review. Among the 42 studies, there were 2 prospective study [24, 25], 17 retrospective studies [26,27,28,29,30,31,32,33,34,35,36,37,38,39,40,41,42] and 23 case reports [43,44,45,46,47,48,49,50,51,52,53,54,55,56,57,58,59,60,61,62,63,64,65].

Fig. 1
figure 1

Preferred Reporting for Systematic Reviews and Meta-Analyses study selection flow diagram

Full size image

Five of the retrospective studies specifically focused on the complications of after shoulder arthroscopy [27, 35, 39, 41, 42]. In the remaining retrospective articles, VTE was reported as complications but was not the focus of the study [26, 33, 34, 36,37,38, 40]. No randomized control trials were identified. The quality assessment of the case reports showed that there was no more than one item in JBI checklist graded as no. Table 1 shows the summary of all the studies included. The MINORS appraisal scores as well as the features of the other studies are listed in Table 2. The risk of bias across the studies is at a moderate level, and the main concern is that most studies were retrospective.

Table 1 Summary of included studies
Full size table
Table 2 Features of non-case report research
Full size table

Incidence and risk factors

Among the 42 included studies, 19 reported the incidence of VTE, which ranged from 0 to 5.71% [24,25,26,27,28,29,30,31,32,33,34,35,36,37,38,39,40,41,42]. The overall incidence of VTE was 0.26% (577/224,636).

VTE risk factors were mentioned in 7 studies [24, 29,30,31, 35, 38, 41]. Jameson et al. [29] retrospectively collected data from a national database. They drew a conclusion that diabetes, > 70 years old and Charlson score ≥ 1 were the risk factors for VTE after arthroscopic shoulder surgeries by calculating the odds ratio (OR). Using a similar method, Sager et al. [38] reported that duration of surgery (> 80 min), male sex, BMI > 30 kg/m2 and ASA III or IV were among the VTE risk factors. While the case–control studies conducted by Schick et al. [41] and Takahashi et al. [24] exclude age, BMI, operation time or smoking habit that were VTE risk factors. Chauhan et al. [64] reported that COVID-19 may be a VTE risk factor as well.

Three patients died from PE after arthroscopic rotator cuff repair in total and all of them were reported in the case reports [52, 56]. These three patients were: (1) a 45-year-old female who had diabetes and a BMI of 27.9 kg/m2 and died 1 day after the surgery, (2) a 62-year-old female who underwent an arthroscopic shoulder surgery lasting for 134 min and (3) a 63-year-old male with significant comorbidities who underwent an arthroscopic shoulder surgery lasting for 190 min. These cases were reported by Kim et al. [52] and Durant et al. [56].

Diagnosis and clinical symptoms

The diagnostic methods for VTE in all the 51 patients were reported in detail [27, 39, 42,43,44,45,46,47,48,49,50,51,52,53,54,55,56, 58, 62,63,64,65]. The most common ones were computed tomography (CT)/computed tomography angiography (CTA)/computed tomography pulmonary angiography (CTPA), which accounted for more than half of the total (22/32) [27, 39, 44, 46, 55, 56, 58, 59, 61,62,63, 65]. Other methods included pulmonary ventilation or/and perfusion scan (5/32) [45, 47, 50, 51, 54] and angiography (2/32) [49, 52]. All the DVT patients received ultrasound. Given its convenience, cheapness and accuracy, ultrasound is not only used to diagnose symptomatic DVT, but also to find the source of pulmonary artery thrombosis or exclude deep vein thrombosis [39, 45, 47, 52, 54, 59].

Among the 51 patients reported in detail [27, 39, 42,43,44,45,46,47,48,49,50,51,52,53,54,55,56, 58, 62,63,64,65], most VTE events took place within 1–14 postoperative day 14 (35/51). All the patients had symptomatic VTE except the 10 patients reported by Takahashi et al. [24]. Common clinical manifestations of PE included dyspnea (17/32) [27, 39, 42, 45,46,47, 51, 52, 54, 55, 58, 59, 61,62,63, 65] and chest/left shoulder/scapular pain (10/32) [27, 46, 50, 55, 59, 62, 65]. The rarer ones included tachycardia (2/32) [61, 63], bloody sputum (1/32) [49] and cardiac arrest (1/32) [44]. Common clinical manifestations of DVT included pain (23/28) [39, 42, 47, 48, 50, 51, 57, 60, 64, 65] and swelling (22/28) [39, 42, 47, 48, 51, 53, 58, 60, 64]. The rarer ones included tenderness (7/28) [43, 53, 60], cold sensation (1/28) [60] and groin discomfort (1/28) [54].

Prophylaxis and treatments

VTE prophylaxis was employed in 15 of the 51 patients reported in detail and 4 retrospective studies focused on the efficacy of prophylaxis [27, 28, 41, 42, 44, 45, 47, 55, 56, 63, 64]. The prophylaxis was either mechanical or chemical or both. Mechanical prophylaxis was more commonly used (12/15), and the compression devices included thromboembolic deterrent (TED) stockings, foot pumps and intermittent pneumatic compression [27, 44, 47, 55, 56, 58, 63]. Chemical prophylaxis was applied in 4 of the 15 patients [45, 55, 56, 64]. Two of them [55, 56] started taking aspirin before surgery and the other two [45, 64] began to take heparin or enoxaparin for VTE prevention from the operation day.

The efficacy of chemical prophylaxis was studied in three of the retrospective studies, and the same conclusion of no significant improvement was reported [28, 41, 42]. In order to identify the factors that were potentially related to VTE following shoulder arthroscopy, Schick et al. [41] conducted a case–control study with the data acquired from the Association of Clinical Elbow and Shoulder Surgeons (ACESS) group. By means of univariate analysis and multivariate logistic regression model, they reported that neither sequential compression devices nor postoperative anticoagulation use was found to be useful in VTE prevention.

Alyea et al. [42] compared the effectiveness of aspirin and mechanical prophylaxis with mechanical prophylaxis alone in preventing VTE following arthroscopic rotator cuff repair in a retrospective case–control study with 914 patients included. The dosage of aspirin was 81 mg per day and the mechanical prophylaxis included compression boots. Their conclusion was that aspirin application did not reduce the incidence of VTE. In an online survey, Randelli et al. [28] retrieved the data of 9385 surgeries from the members of the Italian Society for Knee Surgery, Arthroscopy, Sports Traumatology, Cartilage, and Orthopaedic Technologies (SIGASCOT). They concluded that using sodium enoxaparin or nadroparin for prophylaxis did not result in a significant reduction in the incidence of VTE. No bleeding events were reported in the research. All the three studies mentioned above showed detailed data, and the results are summarized in Fig. 2.

Fig. 2
figure 2

Forest plot for the incidence rate of VTE. VTE venous thromboembolism, CI confidence interval, M-H Mantel–Haenszel

Full size image

The treatments of VTE were mentioned in 45 patients though no included studies focused on the efficacy of treatments. The management of VTE typically included heparinization followed by oral warfarin, and this prescription was adopted in 24 patients (53.3%) [27, 42,43,44, 46, 47, 49, 51, 53,54,55,56, 58,59,60,61, 63]. However, the dosages of the drugs were not specified and the duration of warfarin application ranged from 6 weeks to 12 months, indicating that such scheme varies from patient to patient. Warfarin alone was adopted in 4 patients [39, 42]. Rivaroxaban, a direct oral anticoagulant (DOAC), was reportedly adopted in 9 patients within the last 7 years [42, 60, 62, 65]. No common complications of anticoagulation like hemorrhage was reported.

Discussion

To our knowledge, systematic reviews focusing on VTE after arthroscopic shoulder surgeries only are rare, and this study has the largest sample size. Dattani et al. conducted a systematic review to assess the risk factors for and incidence of VTE complications following shoulder and elbow surgeries [66]. However, they discussed not only arthroscopic shoulder surgeries but also open surgeries. Greene et al. focused on thromboembolic complications in arthroscopic surgeries, but the knee instead of the shoulder surgeries was their primary focus [67]. Researchers have illustrated that VTE was rare after shoulder surgery, and it is even fewer after arthroscopic shoulder surgeries than after shoulder arthroplasty [12, 68]. According to this systematic review, there is a large amount of variability in the incidence of VTE after arthroscopic shoulder surgeries reported in the literature, which ranged from 0 to 5.71% [24,25,26,27,28,29,30,31,32,33,34,35,36,37,38,39,40,41]. The lowest incidence value was shown in a retrospective study, which represented the occurrence of VTE events in anticoagulated patients [33]. The highest incidence value was reported from a prospective cohort study in which 10 asymptomatic VTE events were detected by ultrasound [24]. With 10 large-sample database-dependent studies included, the overall rate of 0.26% is relatively credible [25, 28,29,30,31,32, 35, 37, 38, 41]. This incidence rate demonstrates that the VTE risk for most patients undergoing arthroscopic shoulder surgeries is low. However, surgeons should still be aware of the serious complications in patients after arthroscopic shoulder surgeries due to its potentially fatal risks.

Multiple risk factors are mentioned in the included studies, and the surgery itself elevates the risk of VTE as well. DVT in upper limbs is in majority (60.5%) in this systematic review, while DVT in lower extremities is more common in all patients [69]. A possible theory is that the surgery position may lead to the twisting and stretching of the veins in upper extremities, but it is lacking for validation.

Searching for the risk factors was one of the main focuses of this systematic review. According to previous studies, the risk factors for VTE include advanced age (> 70 years), obesity (BMI ≥ 30 kg/m2), diabetes mellitus, thrombophilia, history of VTE, prolonged operation time, hormone use and immobilization after surgery [70]. However, very few studies have attempted to detect the risk factors in patients undergoing arthroscopic shoulder surgeries. Due to the lack of prospective studies, relatively low incidence and conflicting conclusions from different studies, it is difficult to clearly identify and define every certain risk factor. There are several assessment tools to evaluate the VTE risk of patients, but there are also a few articles that dispute them [71]. Establishing a suitable risk assessment tool is one of the goals of future research.

For surgeons, it is obvious that most of the risk factors such as age and existing comorbidities are not controllable, making primary prevention interventions difficult to implement. Based on the existing evidence, the most effective way to reduce the damage of VTE to patients is to evaluate the patients’ risk levels in detail and take corresponding preventive measures for high-risk patients. The education of patients is also very important. The patients should give an explanation of the relevant risks so that they will be able to seek immediate medical attention when they have symptoms of VTE.

In doing this systematic review, we did find that VTE prophylaxis was not provided to most patients. The reasons may be the rarity of the conditions and the fear of bleeding complications. When applied, the prophylaxis was mainly mechanical since they represent the reasonable, safe, and cost-effective option for most patients [68]. Rapp et al. [12] recommended that the efficacious and low-risk mechanical preventions should be used in all patients when feasible. Chemoprophylaxis was used in 5 studies and no bleeding complication was reported, so it seems that hemorrhage is not a concern [42, 45, 55, 56, 64]. However, the efficacy of chemical prophylaxis is doubtable based on this systematic review. A retrospective case–control study conducted by Alyea et al. [42] suggested that the addition of aspirin chemoprophylaxis does not provide protective effect of reducing the incidence of VTE. Schick et al. [41] stated that postoperative anticoagulation use did not show significant influence on VTE development following shoulder arthroscopy. Previous studies and the guidelines in America and Europe did not recommend routine use of chemoprophylaxis in patients undergoing arthroscopic shoulder surgeries unless the patients were assessed to be high risk [12, 70, 72, 73]. Based on the above information, the preferred prevention method we recommend is mechanical prophylaxis, which provides the limb with intermittent pressure, and this can be a routine. The specific method can be selected according to the actual situations of the hospitals and the patients. For high-risk patients, we recommend using DOACs for prophylaxis besides the adoption of mechanical methods [73].

Though the therapeutic regimens varied from study to study, most cases used heparinization followed by oral warfarin, which is different from the recommendations given by the guideline of the American Society of Hematology [74]. In the guideline, DOACs instead of vitamin K antagonists (VKAs) are the first choice for patients with DVT or/and PE if there is not a hemodynamic compromise. This inconsistency can be explained by the time gap between the literature we reviewed, which include studies conducted before September, 2021, and the publishment of the guideline published in 2020. A proof is that cases reported by Ji et al. [65] in 2021 were treated with rivaroxaban or rivaroxaban combined with low molecular weight heparin and the outcomes were good. Therefore, we still recommend following the guideline unless it is proved to be incorrect by further research.

There are several limitations of this study. First, the level of evidence is low since most of the included studies are case reports. However, this is inevitable since there is still a lack of original research with higher level of evidence. Therefore, publication bias as well as other bias was unavoidable. Second, the included studies were inevitably heterogeneous. For these reasons, the conclusion of this systematic review needs to be interpreted with caution. Finally, this study included only the research published in English, so some studies may be missed, whereas this disadvantage did not result in significant bias, given that most high-quality literature around the world is published in English.

Conclusion

Based on the included studies, the incidence rate of VTE after arthroscopic shoulder surgeries is relatively low. The risk factors for VTE are still unclear. CT/CTA and ultrasound were the mainstream diagnosis methods for PE and DVT, respectively. Current evidence shows that chemical prophylaxis did not deliver significant benefits, since none of the existing studies reported statistically different results. High-quality studies focusing on the prophylaxis and management of VTE population undergoing arthroscopic shoulder surgeries should be done in the future.

Availability of data and materials

All data generated or analyzed during this study are included in this published article.

Abbreviations

VTE:

Venous thromboembolism

DVT:

Deep vein thrombosis

PE:

Pulmonary embolism

TED:

Thromboembolic deterrent

DOAC:

Direct oral anticoagulant

RC:

Rotator cuff

CCI:

Charlson comorbidity index

PRISMA:

Preferred Reporting Items for Systematic Reviews and Meta-Analyses

MINORS:

Methodological Index for Non-Randomized Studies

JBI:

Joanna Briggs Institute

CT:

Computed tomography

CTA:

Computed tomography angiography

CTPA:

Computed tomography pulmonary angiography

ACESS:

Association of Clinical Elbow and Shoulder Surgeons

SIGASCOT:

Italian Society for Knee Surgery, Arthroscopy, Sport Traumatology, Cartilage and Orthopaedic Technologies

VKAs:

Vitamin K antagonists

References

  1. Urwin M, Symmons D, Allison T, Brammah T, Busby H, Roxby M, et al. Estimating the burden of musculoskeletal disorders in the community: the comparative prevalence of symptoms at different anatomical sites, and the relation to social deprivation. Ann Rheum Dis. 1998;57(11):649–55.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  2. Ropars M, Thomazeau H, Huten D. Clavicle fractures. Orthop Traumatol Surg Res. 2017;103(1s):S53–9.

    Article  CAS  PubMed  Google Scholar 

  3. Launonen AP, Lepola V, Saranko A, Flinkkilä T, Laitinen M, Mattila VM. Epidemiology of proximal humerus fractures. Arch Osteoporos. 2015;10:209.

    Article  PubMed  Google Scholar 

  4. Thigpen CA, Shaffer MA, Gaunt BW, Leggin BG, Williams GR, Wilcox RB 3rd. The American Society of Shoulder and Elbow Therapists’ consensus statement on rehabilitation following arthroscopic rotator cuff repair. J Shoulder Elbow Surg. 2016;25(4):521–35.

    Article  PubMed  Google Scholar 

  5. Best MJ, Tanaka MJ. Multidirectional instability of the shoulder: treatment options and considerations. Sports Med Arthrosc Rev. 2018;26(3):113–9.

    Article  PubMed  Google Scholar 

  6. Karakoc Y, Atalay ÏB. Comparison of mini-open versus all-arthroscopic rotator cuff repair: retrospective analysis of a single center. Pan Afr Med J. 2020;37:132.

    Article  PubMed  PubMed Central  Google Scholar 

  7. Black EM, Austin LS, Narzikul A, Seidl AJ, Martens K, Lazarus MD. Comparison of implant cost and surgical time in arthroscopic transosseous and transosseous equivalent rotator cuff repair. J Shoulder Elbow Surg. 2016;25(9):1449–56.

    Article  PubMed  Google Scholar 

  8. Rubenstein WJ, Pean CA, Colvin AC. Shoulder arthroscopy in adults 60 or older: risk factors that correlate with postoperative complications in the first 30 days. Arthroscopy. 2017;33(1):49–54.

    Article  PubMed  Google Scholar 

  9. Shields E, Thirukumaran C, Thorsness R, Noyes K, Voloshin I. An analysis of adult patient risk factors and complications within 30 days after arthroscopic shoulder surgery. Arthroscopy. 2015;31(5):807–15.

    Article  PubMed  Google Scholar 

  10. Jensen AR, Cha PS, Devana SK, Ishmael C, Di Pauli von Treuheim T, D’Oro A, et al. Evaluation of the trends, concomitant procedures, and complications with open and arthroscopic rotator cuff repairs in the medicare population. Orthop J Sports Med. 2017. https://doi.org/10.1177/2325967117731310.

    Article  PubMed  PubMed Central  Google Scholar 

  11. Kelly BC, Constantinescu DS, Vap AR. Arthroscopic and open or mini-open rotator cuff repair trends and complication rates among American board of orthopaedic surgeons part II examinees (2007–2017). Arthroscopy. 2019;35(11):3019–24.

    Article  PubMed  Google Scholar 

  12. Rapp CM, Shields EJ, Wiater BP, Wiater JM. Venous thromboembolism after shoulder arthoplasty and arthroscopy. J Am Acad Orthop Surg. 2019;27(8):265–74.

    Article  PubMed  Google Scholar 

  13. Kahn SR. The post-thrombotic syndrome. Hematol Am Soc Hematol Educ Program. 2016;2016(1):413–8.

    Article  Google Scholar 

  14. Essien EO, Rali P, Mathai SC. Pulmonary embolism. Med Clin N Am. 2019;103(3):549–64.

    Article  PubMed  Google Scholar 

  15. Lung BE, Kanjiya S, Bisogno M, Komatsu DE, Wang ED. Risk factors for venous thromboembolism in total shoulder arthroplasty. JSES Open Access. 2019;3(3):183–8.

    Article  PubMed  PubMed Central  Google Scholar 

  16. Kunutsor SK, Barrett MC, Whitehouse MR, Blom AW. Venous thromboembolism following 672,495 primary total shoulder and elbow replacements: meta-analyses of incidence, temporal trends and potential risk factors. Thromb Res. 2020;189:13–23.

    Article  CAS  PubMed  Google Scholar 

  17. Kolz JM, Aibinder WR, Adams RA, Cofield RH, Sperling JW. Symptomatic thromboembolic complications after shoulder arthroplasty: an update. J Bone Joint Surg Am. 2019;101(20):1845–51.

    Article  PubMed  Google Scholar 

  18. Tashjian RZ, Lilly DT, Isaacson AM, Georgopoulos CE, Bettwieser SP, Burks RT, et al. Incidence of and risk factors for symptomatic venous thromboembolism after shoulder arthroplasty. Am J Orthop (Belle Mead, NJ). 2016;45(6):E379–85.

    PubMed  Google Scholar 

  19. Westermann RW, Pugely AJ, Ries Z, Amendola A, Martin CT, Gao Y, et al. Causes and predictors of 30-day readmission after shoulder and knee arthroscopy: an analysis of 15,167 cases. Arthroscopy. 2015;31(6):1035-40.e1.

    Article  PubMed  Google Scholar 

  20. Rubenstein WJ, Lansdown DA, Feeley BT, Ma CB, Zhang AL. The impact of body mass index on complications after shoulder arthroscopy: Should surgery eligibility be determined by body mass index cutoffs? Arthroscopy. 2019;35(3):741–6.

    Article  PubMed  Google Scholar 

  21. Hill JR, McKnight B, Pannell WC, Heckmann N, Sivasundaram L, Mostofi A, et al. Risk factors for 30-day readmission following shoulder arthroscopy. Arthroscopy. 2017;33(1):55–61.

    Article  PubMed  Google Scholar 

  22. Cancienne JM, Burrus MT, Diduch DR, Werner BC. High altitude is an independent risk factor for venous thromboembolism following arthroscopic rotator cuff repair: a matched case-control study in medicare patients. J Shoulder Elbow Surg. 2017;26(1):7–13.

    Article  PubMed  Google Scholar 

  23. Slim K, Nini E, Forestier D, Kwiatkowski F, Panis Y, Chipponi J. Methodological index for non-randomized studies (minors): development and validation of a new instrument. ANZ J Surg. 2003;73(9):712–6.

    Article  PubMed  Google Scholar 

  24. Takahashi H, Yamamoto N, Nagamoto H, Sano H, Tanaka M, Itoi E. Venous thromboembolism after elective shoulder surgery: a prospective cohort study of 175 patients. J Shoulder Elbow Surg. 2014;23(5):605–12.

    Article  PubMed  Google Scholar 

  25. Imberti D, Dentali F, Ivaldo N, Murena L, Paladini P, Castagna A, et al. Venous thromboembolism in patients undergoing shoulder arthroscopy: findings from the RECOS registry. Clin Appl Thromb Hemost. 2015;21(5):486–8.

    Article  PubMed  Google Scholar 

  26. Brislin KJ, Field LD, Savoie Iii FH. Complications after arthroscopic rotator cuff repair. Arthrosc J Arthrosc Relat Surg. 2007;23(2):124–8.

    Article  Google Scholar 

  27. Hoxie SC, Sperling JW, Cofield RH. Pulmonary embolism following rotator cuff repair. Int J Shoulder Surg. 2008;2(3):49–51.

    Article  PubMed  PubMed Central  Google Scholar 

  28. Randelli P, Castagna A, Cabitza F, Cabitza P, Arrigoni P, Denti M. Infectious and thromboembolic complications of arthroscopic shoulder surgery. J Shoulder Elbow Surg. 2010;19(1):97–101.

    Article  PubMed  Google Scholar 

  29. Jameson SS, James P, Howcroft DWJ, Serrano-Pedraza I, Rangan A, Reed MR, et al. Venous thromboembolic events are rare after shoulder surgery: analysis of a national database. J Shoulder Elbow Surg. 2011;20(5):764–70.

    Article  PubMed  Google Scholar 

  30. Martin CT, Gao Y, Pugely AJ, Wolf BR. 30-day morbidity and mortality after elective shoulder arthroscopy: a review of 9410 cases. J Shoulder Elbow Surg. 2013;22(12):1667-75.e1.

    Article  PubMed  Google Scholar 

  31. Rubenstein WJ, Lansdown DA, Feeley BT, Ma CB, Zhang AL. The impact of body mass index on complications after shoulder arthroscopy: Should surgery eligibility be determined by body mass index cutoffs? Arthrosc J Arthrosc Relat Surg. 2019;35(3):741–6.

    Article  Google Scholar 

  32. Yeung M, Shin JJ, Lesniak BP, Lin A. Complications of arthroscopic versus open biceps tenodesis in the setting of arthroscopic rotator cuff repairs: an analysis of the American board of orthopaedic surgery database. J Am Acad Orthop Surg. 2019;28:113–20.

    Article  Google Scholar 

  33. Flanigan DC, Muchow R, Orwin J, Graf B. Arthroscopy on anticoagulated patients: a retrospective evaluation of postoperative complications. Orthopedics. 2010;33(2):82–6.

    Article  PubMed  Google Scholar 

  34. Rangan A, Brealey SD, Keding A, Corbacho B, Northgraves M, Kottam L, et al. Management of adults with primary frozen shoulder in secondary care (UK FROST): a multicentre, pragmatic, three-arm, superiority randomised clinical trial. Lancet. 2020;396(10256):977–89.

    Article  CAS  PubMed  Google Scholar 

  35. Stone AV, Agarwalla A, Gowd AK, Jacobs CA, Macalena JA, Lesniak BP, et al. Oral contraceptive pills are not a risk factor for deep vein thrombosis or pulmonary embolism after arthroscopic shoulder surgery. Orthop J Sports Med. 2019;7(1):1–5.

    Article  Google Scholar 

  36. Mirzayan R, McCrum CL, Butler RK, Alluri RK. Risk factors for biceps related complications following arthroscopic tenotomy of the long head of the biceps tendon. Orthop J Sports Med. 2018;6(7):1–2.

    Google Scholar 

  37. Owens BD, Williams AE, Wolf JM. Risk factors for surgical complications in rotator cuff repair in a veteran population. J Shoulder Elbow Surg. 2015;24(11):1707–12.

    Article  PubMed  Google Scholar 

  38. Sager B, Ahn J, Tran J, Khazzam M. Timing and risk factors for venous thromboembolism after rotator cuff repair in the 30-day perioperative period. Arthrosc J Arthrosc Relat Surg. 2019;35(11):3011–8.

    Article  Google Scholar 

  39. Kuremsky MA, Cain EL Jr, Fleischli JE. Thromboembolic phenomena after arthroscopic shoulder surgery. Arthrosc J Arthrosc Relat Surg. 2011;27(12):1614–9.

    Article  Google Scholar 

  40. Duralde XA, McClelland WB Jr. The clinical results of arthroscopic transtendinous repair of grade III partial articular-sided supraspinatus tendon tears. Arthroscopy. 2012;28(2):160–8.

    Article  PubMed  Google Scholar 

  41. Schick CW, Westermann RW, Gao Y, Wolf BR, Group A. Thromboembolism following shoulder arthroscopy: a retrospective review. Orthop J Sports Med. 2014. https://doi.org/10.1177/2325967114559506.

    Article  PubMed  PubMed Central  Google Scholar 

  42. Alyea E, Gaston T, Austin LS, Wowkanech C, Cypel B, Pontes M, et al. The effectiveness of aspirin for venous thromboembolism prophylaxis for patients undergoing arthroscopic rotator cuff repair. Orthopedics. 2019;42(2):E187–92.

    Article  PubMed  Google Scholar 

  43. Burkhart SS. Deep venous thrombosis after shoulder arthroscopy. Arthrosc J Arthrosc Relat Surg Off Publ Arthrosc Assoc N Am Int Arthrosc Assoc. 1990;6(1):61–3.

    Article  CAS  Google Scholar 

  44. Yamamoto T, Tamai K, Akutsu M, Tomizawa K, Sukegawa T, Nohara Y. Pulmonary embolism after arthroscopic rotator cuff repair: a case report. Case Rep Orthop. 2013;2013:801752.

    PubMed  PubMed Central  Google Scholar 

  45. Polzhofer GK, Petersen W, Hassenpflug J. Thromboembolic complication after arthroscopic shoulder surgery. Arthroscopy. 2003;19(9):E129–32.

    Article  PubMed  Google Scholar 

  46. Cortés ZE, Hammerman SM, Gartsman GM. Pulmonary embolism after shoulder arthroscopy: Could patient positioning and traction make a difference? J Shoulder Elbow Surg. 2007;16(2):e16–7.

    Article  PubMed  Google Scholar 

  47. Creighton RA, Cole BJ. Upper extremity deep venous thrombosis after shoulder arthroscopy: a case report. J Shoulder Elbow Surg. 2007;16(1):e20–2.

    Article  PubMed  Google Scholar 

  48. Bongiovanni SL, Ranalletta M, Guala A, Maignon GD. Case reports: heritable thrombophilia associated with deep venous thrombosis after shoulder arthroscopy. Clin Orthop Relat Res. 2009;467(8):2196–9.

    Article  PubMed  PubMed Central  Google Scholar 

  49. Hariri A, Nourissat G, Dumontier C, Doursounian L. Pulmonary embolism following thrombosis of the brachial vein after shoulder arthroscopy. A case report. Orthop Traumatol Surg Res. 2009;95(5):377–9.

    Article  CAS  PubMed  Google Scholar 

  50. Dal Molin FF, Dal Molin SF. Thromboembolic complication after arthroscopic shoulder surgery. Rev Bras Ortop. 2010;45(3):312–5.

    Google Scholar 

  51. Garofalo R, Notarnicola A, Moretti L, Moretti B, Marini S, Castagna A. Deep vein thromboembolism after arthroscopy of the shoulder: two case reports and a review of the literature. BMC Musculoskel Disord. 2010;11:65.

    Article  Google Scholar 

  52. Kim SJ, Yoo KY, Lee HG, Kim WM, Jeong CW, Lee HJ. Fatal pulmonary embolism caused by thrombosis of contralateral axillary vein after arthroscopic right rotator cuff repair. Korean J Anesthesiol. 2010;59:S172–5.

    Article  PubMed  PubMed Central  Google Scholar 

  53. Delos D, Rodeo SA. Venous thrombosis after arthroscopic shoulder surgery: pacemaker leads as a possible cause: pacemaker leads as a possible cause. HSS J Musculoskel J Hosp Spec Surg. 2011;7(3):282–5.

    Article  Google Scholar 

  54. Laubscher PH, Ferguson MC. Venous thrombotic events in arthroscopic shoulder surgery—a case report and review of the literature. SA Orthop J. 2011;10(2):78–80.

    Google Scholar 

  55. Edgar R, Nagda S, Huffman R, Namdari S. Pulmonary embolism after shoulder arthroscopy. Orthopedics. 2012;35(11):e1673–6.

    Article  PubMed  Google Scholar 

  56. Durant TJS, Cote MP, Arciero RA, Mazzocca AD. Fatal pulmonary embolism after arthroscopic rotator cuff repair: a case series. Muscles Ligaments Tendons J. 2014;4(2):232–7.

    Article  PubMed  PubMed Central  Google Scholar 

  57. Durant TJS, Swanson BT, Cote MP, Allen DA, Arciero RA, Mazzocca AD. Upper extremity deep venous thromboembolism following arthroscopic labral repair of the shoulder and biceps tenodesis: a case report. Int J Sports Phys Ther. 2014;9(3):377–82.

    PubMed  PubMed Central  Google Scholar 

  58. Goldhaber NH, Lee CS. Isolated pulmonary embolism following shoulder arthroscopy. Case Rep Ortho. 2014;2014:279082.

    Google Scholar 

  59. Gwark JY, Koh J-S, Park HB. Pulmonary embolism after arthroscopic rotator cuff repair—a case report. Clin Shoulder Elbow. 2014;17(1):31–5.

    Article  Google Scholar 

  60. Manaqibwala MI, Ghobrial IE, Curtis AS. Upper extremity thrombosis presenting as medial elbow pain after shoulder arthroscopy. Case Rep Orthop. 2014;2014:653146.

    PubMed  PubMed Central  Google Scholar 

  61. Matthews JM, Wessel SS, Pate RC, Chong AC. Pulmonary embolism after arthroscopic bankart and rotator cuff repair. Kansas J Med. 2017;10(2):43–6.

    Article  Google Scholar 

  62. Yagnatovsky M, Dai AZ, Zacchilli M, Jazrawi LM. Acute pulmonary embolism after arthroscopic glenoid labral repair and subacromial decompression: case report and review of the literature. Phys Sportsmed. 2018;46(1):135–8.

    Article  PubMed  Google Scholar 

  63. Watanabe H, Nagase Y, Tamai K, Tanaka S. Pulmonary embolism associated with upper extremity deep venous thrombosis after shoulder arthroscopy: a case report. J Orthop Sci. 2019;24(4):746–9.

    Article  PubMed  Google Scholar 

  64. Chauhan A, Villacis D, Boente R, Romeo AA. Venous thromboembolism after arthroscopic rotator cuff repair in a patient with a negative presurgical SARS-CoV-2 test who developed symptomatic COVID-19 three days after surgery. J Shoulder Elbow Surg. 2021;30(5):e251–5.

    Article  PubMed  PubMed Central  Google Scholar 

  65. Ji L, Lyu C, Feng M, Qiang H. Asymptomatic pulmonary embolism after shoulder arthroscopy: case report and literature review. Orthop Surg. 2021;13(3):1119–25.

    Article  PubMed  PubMed Central  Google Scholar 

  66. Dattani R, Smith CD, Patel VR. The venous thromboembolic complications of shoulder and elbow surgery: a systematic review. Bone Joint J. 2013;95(1):70–4.

    Article  PubMed  Google Scholar 

  67. Greene JW, Deshmukh AJ, Cushner FD. Thromboembolic complications in arthroscopic surgery. Sports Med Arthrosc Rev. 2013;21(2):69–74.

    Article  PubMed  Google Scholar 

  68. Aibinder WR, Sanchez-Sotelo J. Venous thromboembolism prophylaxis in shoulder surgery. Orthop Clin N Am. 2018;49(2):257.

    Article  Google Scholar 

  69. Heil J, Miesbach W, Vogl T, Bechstein WO, Reinisch A. Deep vein thrombosis of the upper extremity. Deutsches Arzteblatt Int. 2017;114(14):244–9.

    Google Scholar 

  70. Afshari A, Ageno W, Ahmed A, Duranteau J, Faraoni D, Kozek-Langenecker S, et al. European guidelines on perioperative venous thromboembolism prophylaxis: executive summary. Eur J Anaesthesiol. 2018;35(2):77–83.

    Article  PubMed  Google Scholar 

  71. Pandor A, Tonkins M, Goodacre S, Sworn K, Clowes M, Griffin XL, et al. Risk assessment models for venous thromboembolism in hospitalised adult patients: a systematic review. BMJ Open. 2021;11(7):e045672.

    Article  PubMed  PubMed Central  Google Scholar 

  72. Schünemann HJ, Cushman M, Burnett AE, Kahn SR, Beyer-Westendorf J, Spencer FA, et al. American Society of Hematology 2018 guidelines for management of venous thromboembolism: prophylaxis for hospitalized and nonhospitalized medical patients. Blood Adv. 2018;2(22):3198–225.

    Article  PubMed  PubMed Central  Google Scholar 

  73. Anderson DR, Morgano GP, Bennett C, Dentali F, Francis CW, Garcia DA, et al. American Society of Hematology 2019 guidelines for management of venous thromboembolism: prevention of venous thromboembolism in surgical hospitalized patients. Blood Adv. 2019;3(23):3898–944.

    Article  PubMed  PubMed Central  Google Scholar 

  74. Ortel TL, Neumann I, Ageno W, Beyth R, Clark NP, Cuker A, et al. American Society of Hematology 2020 guidelines for management of venous thromboembolism: treatment of deep vein thrombosis and pulmonary embolism. Blood Adv. 2020;4(19):4693–738.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

Download references

Acknowledgements

None.

Funding

This study was funded by the National Natural Science Foundation of China (82072514) and the Science and Technology Department of Sichuan Province (2021YFS0238).

Author information

Author notes

  1. Tao Li and Yinghao Li contributed equally to this work.

Authors and Affiliations

  1. Department of Orthopedics, Orthopedic Research Institute, West China Hospital, Sichuan University, No. 37, Guoxue Road, Wuhou District, Chengdu, 610041, Sichuan Province, People’s Republic of China

    Tao Li, Yinghao Li, Long Pang & Xin Tang

  2. West China School of Medicine, Sichuan University, Chengdu, People’s Republic of China

    Linmin Zhang

  3. Department of Respiratory and Critical Care Medicine, West China Hospital, West China School of Nursing, Sichuan University, No. 37, Guoxue Road, Wuhou District, Chengdu, Sichuan Province, People’s Republic of China

    Jing Zhu

Authors
  1. Tao Li
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Yinghao Li
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Linmin Zhang
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Long Pang
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. Xin Tang
    View author publications

    You can also search for this author in PubMed Google Scholar

  6. Jing Zhu
    View author publications

    You can also search for this author in PubMed Google Scholar

Contributions

XT proposed the research idea and participated in the design of the study. JZ participated in the design of the study. LZ participated in the literature selection and data extraction. LP participated in the literature selection and data extraction. TL performed the quality assessment and data summarization. YL performed the data summarization and drafted the manuscript. All authors read and approved the final manuscript.

Corresponding authors

Correspondence to Xin Tang or Jing Zhu.

Ethics declarations

Ethics approval and consent to participate

Not applicable.

Informed consent

Not applicable.

Competing interests

The authors declare that they have no competing interests.

Additional information

Publisher's Note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Rights and permissions

Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated in a credit line to the data.

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Li, T., Li, Y., Zhang, L. et al. Venous thromboembolism after arthroscopic shoulder surgery: a systematic review. J Orthop Surg Res 18, 103 (2023). https://doi.org/10.1186/s13018-023-03592-0

Download citation

  • Received:

  • Accepted:

  • Published:

  • DOI: https://doi.org/10.1186/s13018-023-03592-0

Keywords

Journal of Orthopaedic Surgery and Research

ISSN: 1749-799X